NICM
IMGN

Neo Ivy Capital Management’s Immunogen Inc IMGN Stock Holding History

Neo Ivy Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-55,120
Closed -$875K – 484
2023
Q3 		$875K Buy
55,120
+31,864
+137% +$530K 0.38% 97
2023
Q2 		$439K Buy
+23,256
New +$275K 0.23% 140

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Neo Ivy Capital Management's IMGN Position: Q4 2023 in Review

Neo Ivy Capital Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 55,120 shares — an estimated $875K sold.

Neo Ivy Capital Management first reported a position in IMGN in Q2 2023 and held it in 2 quarters. The position peaked at $875K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Neo Ivy Capital Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Neo Ivy Capital Management sold 55,120 Immunogen Inc shares in Q4 2023, an estimated $875K.
  • Neo Ivy Capital Management first reported a position in Immunogen Inc in Q2 2023 and held it in 2 quarters.
  • Neo Ivy Capital Management's Immunogen Inc position peaked at $875K in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Neo Ivy Capital Management's 13F filing for Q4 2023, filed 26 Feb 2024.